Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells

Marie-Ève Roy(Université du Québec à Montréal), Borhane Annabi(Université du Québec à Montréal)

Anti-Cancer Drugs

June 18, 2024

10.1097/cad.0000000000001627

Cited by 16

Related Papers

Gut microbiota influence anastomotic healing in colorectal cancer surgery through modulation of mucosal proinflammatory cytokines

|Gut|2022|113

Evidence for Transcriptional Regulation of the Glucose-6-Phosphate Transporter by HIF-1<i>α</i>: Targeting G6PT with Mumbaistatin Analogs in Hypoxic Mesenchymal Stromal Cells

|Stem Cells|2008|53

EGCG Prevents the Onset of an Inflammatory and Cancer-Associated Adipocyte-like Phenotype in Adipose-Derived Mesenchymal Stem/Stromal Cells in Response to the Triple-Negative Breast Cancer Secretome

|Nutrients|2022|40

A prostate secretory protein94‐derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: Implication in tumor angiogenesis

|International Journal of Cancer|2005|36

MT1-MMP Cooperates with TGF-β Receptor-Mediated Signaling to Trigger SNAIL and Induce Epithelial-to-Mesenchymal-like Transition in U87 Glioblastoma Cells

|International Journal of Molecular Sciences|2021|35